| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Medicine (J.P.C., M.C.C., F.F.C.), Research Area, Molecular Endocrinology Laboratory, Complejo Hospitalario Universitario de Santiago (CHUS) and University of Santiago de Compostela, E-15705 Santiago de Compostela, Spain; Institut National de la Sante et de la Recherche Medicale (S.E.M., C.L.-C.), Unite 36, College de France, Chaire de Medecine Experimentale, 75231 Paris cedex 05, France; and Huffington Center on Aging and Department of Molecular and Cellular Biology (R.G.S.), Baylor College of Medicine, Houston, Texas 77030
Address all correspondence and requests for reprints to: Felipe F. Casanueva, Molecular and Cellular Endocrinology Laboratory, Department of Medicine, Complejo Hospitalario Universitario de Santiago-Universidad de Santiago de Compostela, P.O. Box 56, E-15780 Santiago de Compostela, Spain. E-mail: endocrine{at}usc.es.
In this study, a sequential analysis of pathways involved in the regulation of GH secretagogue receptor subtype 1a (GHSR-1a) signaling has been undertaken to characterize the process of rapid desensitization that is observed after ghrelin binding. This process was evaluated by studying the binding of [125I]ghrelin, measurement of intracellular calcium mobilization, and confocal microscopy. The results indicate that GHSR-1a is mainly localized at the plasma membrane under unstimulated conditions and rapidly desensitizes after stimulation. The agonist-dependent desensitization is not mediated by protein kinase C because phorbol ester, phorbol-12-myristate-13-acetate, failed to block the ghrelin-induced calcium response. The ghrelin/GHSR-1a complex progressively disappears from the plasma membrane after 20 min exposure to ghrelin and accumulates in the perinuclear region after 60 min. Colocalization of the internalized GHSR-1a with the early endosome marker (EEA1) after 20 min exposure to ghrelin suggests that endocytosis occurs via clathrin-coated pits, which is consistent with the lack of internalization of this receptor observed after potassium depletion. Different from other G protein-coupled receptors, GHSR-1a showed slow recycling. Surface binding slowly recovered after agonist treatment and returned to control levels within 360 min. Furthermore, inhibition of vacuolar H+-ATPases prevented recycling of the receptor, suggesting that the nondissociation of the ligand/receptor complex is responsible for this effect. The GHSR-1a internalization may explain the characteristic physiological responses mediated by this receptor.
This article has been cited by other articles:
![]() |
A. Stengel, M. Goebel, M. Million, M. P. Stenzel-Poore, P. Kobelt, H. Monnikes, Y. Tache, and L. Wang Corticotropin-Releasing Factor-Overexpressing Mice Exhibit Reduced Neuronal Activation in the Arcuate Nucleus and Food Intake in Response to Fasting Endocrinology, January 1, 2009; 150(1): 153 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. F. Casanueva, J. P. Camina, M. C. Carreira, Y. Pazos, J. L. Varga, and A. V. Schally Growth hormone-releasing hormone as an agonist of the ghrelin receptor GHS-R1a PNAS, December 23, 2008; 105(51): 20452 - 20457. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Holliday, B. Holst, E. A. Rodionova, T. W. Schwartz, and H. M. Cox Importance of Constitutive Activity and Arrestin-Independent Mechanisms for Intracellular Trafficking of the Ghrelin Receptor Mol. Endocrinol., December 1, 2007; 21(12): 3100 - 3112. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C Carreira, J. P Camina, E. Diaz-Rodriguez, R. Alvear-Perez, C. Llorens-Cortes, and F. F Casanueva Adenosine does not bind to the growth hormone secretagogue receptor type-1a (GHS-R1a). J. Endocrinol., October 1, 2006; 191(1): 147 - 157. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. De Smet, I. Depoortere, D. Moechars, Q. Swennen, B. Moreaux, K. Cryns, J. Tack, J. Buyse, B. Coulie, and T. L. Peeters Energy Homeostasis and Gastric Emptying in Ghrelin Knockout Mice J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 431 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Kitazawa, B De Smet, K Verbeke, I Depoortere, and T L Peeters Gastric motor effects of peptide and non-peptide ghrelin agonists in mice in vivo and in vitro Gut, August 1, 2005; 54(8): 1078 - 1084. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kola, E. Hubina, S. A. Tucci, T. C. Kirkham, E. A. Garcia, S. E. Mitchell, L. M. Williams, S. A. Hawley, D. G. Hardie, A. B. Grossman, et al. Cannabinoids and Ghrelin Have Both Central and Peripheral Metabolic and Cardiac Effects via AMP-activated Protein Kinase J. Biol. Chem., July 1, 2005; 280(26): 25196 - 25201. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Holst, N. D. Holliday, A. Bach, C. E. Elling, H. M. Cox, and T. W. Schwartz Common Structural Basis for Constitutive Activity of the Ghrelin Receptor Family J. Biol. Chem., December 17, 2004; 279(51): 53806 - 53817. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |